Clinical Trial Update: IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites

View source ↗

Summary

IMPAACT P1073 evaluated Immune Reconstitution Inflammatory Syndrome in infants and children initiating HAART at international sites; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Immune Reconstitution Inflammatory Syndrome

Snippet

Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group | Conditions: IRIS, HIV | Status: COMPLETED